Finance

Mga Listahan
M1CK34:BVMF
Mckesson Corp Bdr
R$73.22
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3  ·   BRL
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa M1CK34...
Buksan
R$72.80
Mataas
R$73.43
Mababa
R$72.80
Mkt. cap
111.43B
Avg. na dami
296.00
Dami
0.00
Mataas nang 52-wk
R$81.67
Mababa nang 52-wk
R$55.63
Mga natitirang share
116.59M
Bilang ng mga empleyado
42K
Buksan
R$72.80
Mataas
R$73.43
Mababa
R$72.80
Mkt. cap
111.43B
Avg. na dami
296.00
Dami
0.00
Mataas nang 52-wk
R$81.67
Mababa nang 52-wk
R$55.63
Mga natitirang share
116.59M
Bilang ng mga empleyado
42K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
Tungkol sa Mckesson Corp Bdr
CEOBrian S. Tyler
Mga Empleyado42.3K
Itinatag1835
Headquarters-
SektorHealth care provider
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
103.15B
106.16B
96.30B
105.38B
Gastusin sa mga naibentang produkto
99.61B
102.49B
92.25B
101.70B
Halaga ng kita
99.61B
102.49B
92.25B
101.70B
Mga gastos sa pananaliksik at pag-develop
-
-
-
-
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
2.12B
2.03B
1.92B
2.26B
Gastos sa pagpapatakbo
2.12B
2.03B
1.92B
2.26B
Kabuuang gastos sa pagpapatakbo
101.73B
104.52B
94.17B
103.96B
Kita sa pagpapatakbo
1.42B
1.64B
2.13B
1.42B
Iba pang hindi kita sa pagpapatakbo
62.00M
74.00M
-156.00M
66.00M
EBT na may mga hindi karaniwang item
1.40B
1.63B
2.12B
1.31B
EBT na hindi kasama ang mga hindi karaniwang item
1.40B
1.65B
2.10B
1.41B
Gastos sa buwis sa kita
232.00M
380.00M
270.00M
276.00M
Epektibong rate ng buwis
16.63%
23.31%
12.71%
21.10%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
1.11B
1.19B
1.68B
614.00M
Margin ng kabuuang kita
1.08%
1.12%
1.75%
0.58%
Kita bawat share
9.86
9.34
11.69
9.93
Kita sa interes at investment
-
-
179.00M
-
Gastos sa interes
-74.00M
-63.00M
-61.00M
-77.00M
Mga net na gastos sa interes
-74.00M
-63.00M
118.00M
-77.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
1.60B
1.83B
2.19B
1.62B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-102.00M
-
-488.00M
-6.00M
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google